Jazz sues generics makers for infringement on cannabis-derived epilepsy drug

Jazz is suing Teva, Apotex, Alkem and a few other generic drugmakers for alleged infringement on the cannabis-derived therapy, the company said in a Securities and Exchange Commission filing. The drug won its FDA approval back in 2018 as the first therapy comprised of an active ingredient derived from marijuana.